111 related articles for article (PubMed ID: 18320023)
21. CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach.
Bhattacharyya N; Gupta S; Sharma S; Soni A; Bagabir SA; Bhattacharyya M; Mukherjee A; Almalki AH; Alkhanani MF; Haque S; Ray AK; Malik MZ
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330393
[TBL] [Abstract][Full Text] [Related]
22. Four-protein model for predicting prognostic risk of lung cancer.
Wang X; Wang M; Feng L; Song J; Dong X; Xiao T; Cheng S
Front Med; 2022 Aug; 16(4):618-626. PubMed ID: 35266102
[TBL] [Abstract][Full Text] [Related]
23. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Zhu L; Retana D; García-Gómez P; Álvaro-Espinosa L; Priego N; Masmudi-Martín M; Yebra N; Miarka L; Hernández-Encinas E; Blanco-Aparicio C; Martínez S; Sobrino C; Ajenjo N; Artiga MJ; Ortega-Paino E; Torres-Ruiz R; Rodríguez-Perales S; ; Soffietti R; Bertero L; Cassoni P; Weiss T; Muñoz J; Sepúlveda JM; González-León P; Jiménez-Roldán L; Moreno LM; Esteban O; Pérez-Núñez Á; Hernández-Laín A; Toldos O; Ruano Y; Alcázar L; Blasco G; Fernández-Alén J; Caleiras E; Lafarga M; Megías D; Graña-Castro O; Nör C; Taylor MD; Young LS; Varešlija D; Cosgrove N; Couch FJ; Cussó L; Desco M; Mouron S; Quintela-Fandino M; Weller M; Pastor J; Valiente M
EMBO Mol Med; 2022 Mar; 14(3):e14552. PubMed ID: 35174975
[TBL] [Abstract][Full Text] [Related]
24. Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression.
Poggio P; Sorge M; Seclì L; Brancaccio M
Front Cell Dev Biol; 2021; 9():735529. PubMed ID: 34722515
[TBL] [Abstract][Full Text] [Related]
25. Predictive Study of the Active Ingredients and Potential Targets of
Gong YB; Fu SJ; Wei ZR; Liu JG
Evid Based Complement Alternat Med; 2021; 2021():1480925. PubMed ID: 34194515
[TBL] [Abstract][Full Text] [Related]
26. Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma.
Marrugal Á; Ferrer I; Gómez-Sánchez D; Quintanal-Villalonga Á; Pastor MD; Ojeda L; Paz-Ares L; Molina-Pinelo S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802597
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of Paclitaxel and 17AAG-loaded Poly-ε-Caprolactone Nanoparticles for Breast Cancer Treatment.
Berko YA; Funmilola AF; Akala EO
J Pharm Drug Deliv Res; 2021 Jan; 10(1):. PubMed ID: 33681397
[TBL] [Abstract][Full Text] [Related]
28. Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis.
Park S; Jeon JH; Park JA; Choi JK; Lee Y
Cell Stress Chaperones; 2021 Jan; 26(1):129-139. PubMed ID: 32869129
[TBL] [Abstract][Full Text] [Related]
29. Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells.
Min S; Wang X; Du Q; Gong H; Yang Y; Wang T; Wu N; Liu X; Li W; Zhao C; Shen Y; Chen Y; Wang X
Cancer Biol Ther; 2020 Aug; 21(8):698-708. PubMed ID: 32489150
[TBL] [Abstract][Full Text] [Related]
30. Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib.
Wang L; Fan Y; Mei H; Liu Y; Zhang L; Xu J; Huang X
Cancer Manag Res; 2019; 11():8937-8945. PubMed ID: 31802936
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells.
Tabata M; Tsubaki M; Takeda T; Tateishi K; Maekawa S; Tsurushima K; Imano M; Satou T; Ishizaka T; Nishida S
Clin Exp Med; 2020 Feb; 20(1):63-71. PubMed ID: 31650359
[TBL] [Abstract][Full Text] [Related]
32. Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Marrugal Á; Ferrer I; Pastor MD; Ojeda L; Quintanal-Villalonga Á; Carnero A; Molina-Pinelo S; Paz-Ares L
Cells; 2019 Jul; 8(8):. PubMed ID: 31370342
[TBL] [Abstract][Full Text] [Related]
33. Identification of the targets of hematoporphyrin derivative in lung adenocarcinoma using integrated network analysis.
Yin H; Yu Y
Biol Res; 2019 Feb; 52(1):4. PubMed ID: 30717818
[TBL] [Abstract][Full Text] [Related]
34. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
[TBL] [Abstract][Full Text] [Related]
35. A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.
Wang R; Cai Y; Zhang B; Wu Z
Int J Mol Med; 2018 Mar; 41(3):1377-1384. PubMed ID: 29286069
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
Jabs V; Edlund K; König H; Grinberg M; Madjar K; Rahnenführer J; Ekman S; Bergkvist M; Holmberg L; Ickstadt K; Botling J; Hengstler JG; Micke P
PLoS One; 2017; 12(11):e0187246. PubMed ID: 29112949
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinoma.
Tsukao Y; Yamasaki M; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
Oncol Lett; 2017 Mar; 13(3):1819-1825. PubMed ID: 28454329
[TBL] [Abstract][Full Text] [Related]
38. Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model.
Vartholomaiou E; Madon-Simon M; Hagmann S; Mühlebach G; Wurst W; Floss T; Picard D
Oncotarget; 2017 Mar; 8(11):17428-17442. PubMed ID: 28407697
[TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
Li QQ; Hao JJ; Zhang Z; Krane LS; Hammerich KH; Sanford T; Trepel JB; Neckers L; Agarwal PK
Sci Rep; 2017 Mar; 7(1):201. PubMed ID: 28298630
[TBL] [Abstract][Full Text] [Related]
40. Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells.
Rouhi A; Miller C; Grasedieck S; Reinhart S; Stolze B; Döhner H; Kuchenbauer F; Bullinger L; Fröhling S; Scholl C
Oncotarget; 2017 Jan; 8(5):7678-7690. PubMed ID: 28032595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
